Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-31

FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Temazepam from Actavis Pharma, Inc., indicating approval of an additional aspect of the product's labeling/approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)